Mudit K, Jain, PhD
Strategic Healthcare Investment Partners (S.H.I.P.)
Mudit is a Founding General Partner of Strategic Healthcare Investment Partners (S.H.I.P.), and the CEO and co-founder of NuXcel, a medical device accelerator. Mudit also co-founded and serves as Chairman of the Board of ShiraTronics, Inc., a NuXcel spin off company.
Mudit has over two decades of medical device industry experience across company formation, R&D, and business development. In addition to his private venture capital experiences at S.H.I.P, and Synergy Life Science Partners, Mudit also brings a strategic investment perspective based on his tenure at Johnson and Johnson Development Corporation.
Mudit has served on the boards of several medical device companies, from early to commercial growth stage, resulting in successful IPOs and M&A transactions. Mudit current serves on the boards of Inspire Medical Systems (NYSE: INSP), Neochord, Inc., ShiraTronics, Inc., CVRx, Inc., and Noctrix, Inc. Some of his prior investments/board responsibilities include Irhythm Technologies (NSDQ:IRTC), Aptus Endosystems (Acqd. by Medtronic), CardioMEMS (Acqd. by St. Jude Medical), Impres Medical (Acqd. by J&J), and Neuspera,Inc. Mudit also serves on the Board of Visitors of the Graduate School at Duke University, External Advisory Board of John Hopkins University Center for Bioengineering Innovation and Design.
Prior to his investing career, Mudit held operational roles in the Cardiac Rhythm Management Division of Guidant Corporation, and played a key role in developing novel device technologies for heart failure, remote cardiac monitoring, and cardiac ablation. Mudit holds 8 issued patents and has authored several peer reviewed publications.
Mudit graduated with a B.E. in Electrical Engineering from REC, Nagpur, India, where he was a gold medal recipient for academic achievements. He received his Ph.D. in Biomedical Engineering from Duke University, and his M.B.A. from the Wharton School, University of Pennsylvania.